Edition:
United States

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

29.42USD
20 Jul 2018
Change (% chg)

$0.57 (+1.99%)
Prev Close
$28.85
Open
$28.85
Day's High
$29.45
Day's Low
$28.45
Volume
41,735
Avg. Vol
80,835
52-wk High
$37.45
52-wk Low
$22.10

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Angus Russell

62 2014 Independent Chairman of the Board

L. Daniel Browne

56 Co-Founder, President, Chief Executive Officer, Director

Cyril Allouche

46 2018 Principal Financial Officer and Principal Accounting Officer

Abhay Joshi

55 2015 Chief Operating Officer

Caryn McDowell

2018 Senior Vice President, General Counsel, and Corporate Secretary